Skip to content

Clinical trials

Epilepsies, Myoclonic trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Epilepsies, Myoclonic Country / region: Canada Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20162
20172
20182
20191
20202
20211
20222
20231
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Terminated4
Recruiting2
Active, not recruiting2
Unknown status1
Enrolling by invitation1
Not yet recruiting1
No longer available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Takeda4
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.3
Eisai Inc.2
Longboard Pharmaceuticals2
Elizabeth Donner1
Epygenix1
Ionis Pharmaceuticals, Inc.1
Loulou Foundation1
University Health Network, Toronto1
University of Saskatchewan1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Epilepsies, Myoclonic18
Epilepsy9
Seizures9
Lennox Gastaut Syndrome7
Brain Diseases4
Neurodevelopmental Disorders2
Spasms, Infantile2
Central Nervous System Diseases1
Drug Resistant Epilepsy1
Hypoxia-Ischemia, Brain1

Trials

Showing 51 to 18 of 18. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.